Trial Profile
A prospective randomized trial to compare efficacy of topical loteprednol etabonate 0.5% versus cyclosporine-a 0.05% for treatment of dry eye syndrome following hematopoietic stem cell transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate (Primary) ; Ciclosporin
- Indications Dry eyes
- Focus Therapeutic Use
- 04 Feb 2016 New trial record